Digital Look

Welcome to Digital Look++,
you are not logged in

Hikma Pharmaceuticals (HIKL)

1,554.00p

Select chart: EPS | Revenue

Period Ending	Period	Revenue ($m)	Pre-tax ($m)	EPS	Dividend
30-Jun-25	Interim	1,658.00	295.00	122.00¢	36.00¢

Year Ending	Revenue ($m)	Pre-tax ($m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Dec-20	2,341.00	558.00	172.90¢	19.6	1.3	+15%	50.00¢	1.5%
31-Dec-21	2,553.00	544.00	194.80¢	15.3	1.2	+13%	54.00¢	1.8%
31-Dec-22	2,517.00	233.00	181.00¢	11.6	n/a	-7%	56.00¢	2.7%
31-Dec-23	2,875.00	281.00	223.00¢	10.7	0.5	+23%	72.00¢	3.0%
31-Dec-24	3,127.00	455.00	224.00¢	12.0	n/a	0%	80.00¢	3.0%

Year Ending	Revenue (£m)	Pre-tax (£m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Dec-25	3,326.84	703.53	166.20p	9.4	52.2	0%	60.69p	0.0%
31-Dec-26	3,513.87	760.08	180.29p	8.6	1.0	+8%	64.39p	0.0%
31-Dec-27	3,738.17	828.38	199.90p	7.8	0.7	+11%	70.58p	0.0%

	5 Yr High	5 Yr Low	5 Yr Avg	Curr / Avg
Latest	19.91	10.14	13.39	0.70

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 5 minutes.

Note 2: Forecast figures based on normalised accounts.